Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Neumora Therapeutics, Inc.

NASDAQ: NMRA · Life Sciences · 3 alerts · CIK 1885522

Share price
$0.3695Close, Nov 16
Market cap
$69.7M
Shares outstanding
188.69MLatest SEC cover page
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Neumora Therapeutics, Inc. filings on SEC EDGAR ↗

8:16 AM ET 10-Q
Financial Results

Neumora Therapeutics Q3 2026 Results: Net Loss of $34.4M, Loss Narrows

Neumora Therapeutics reported a net loss of $34.4 million for the third quarter of 2026, an improvement from the $56.8 million loss in the prior year period. The company's cash and cash equivalents decreased significantly to $85.7 million as of September 30, 2026, compared to $182.5 million at the end of 2025, while total stockholders' equity fell to $18.6 million.

Key figure
Net loss $34.4M
8:04 AM ET 8-K
Business Update

Neumora Therapeutics Business Update

Neumora Therapeutics reported third quarter 2026 financial results and provided a pipeline update, including the submission of an IND application for NMRA-215 in obesity. The company reported a cash position of $85.7 million and noted that it will require substantial additional funding to continue operations and complete product development.

4:05 PM ET 8-K
Nasdaq/NYSE Compliance Notice

Neumora Therapeutics Nasdaq/NYSE Compliance Notice

Neumora Therapeutics received a deficiency notice from Nasdaq for failing to maintain the $1.00 minimum bid price requirement for its common stock. The company has 180 calendar days, until April 26, 2027, to regain compliance by having its stock close at $1.00 or higher for at least ten consecutive business days.

Counterparty
The Nasdaq Stock Market LLC
Term
180 days

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.